Identifying the radioprotective potential of radiation-resistant fungi using Drosophila
Project Number1R21OD034471-01A1
Former Number1R21OD034471-01
Contact PI/Project LeaderCOX, RACHEL TAFEL
Awardee OrganizationHENRY M. JACKSON FDN FOR THE ADV MIL/MED
Description
Abstract Text
PROJECT SUMMARY:
Ionizing radiation causes double strand breaks and damages the protein-based mechanisms responsible for
their repair. This makes mitotic cells in the bone marrow, gut and reproductive organs highly susceptible to
ionizing radiation damage. In addition, as humans age, we become more susceptible to the effects of radiation
likely due to inherent accumulated cellular damage we accrue over time. There are very few pharmaceutical
countermeasures approved for mitigation of acute radiation damage, and none are effective for prophylactic
intervention. Given the use of nuclear power plants, the proliferation of nuclear arms and increased global
interest in space flight with its concomitant cosmic ray exposure, there is a pressing need to identify medicinal
sources of radioprophylactics.
Fungi are sources of diverse and powerful pharmaceuticals, and many strains of fungi are remarkably
radioresistant. Various fungi have been found growing in the heavily irradiated environments of the Chernobyl
Nuclear Power Plant and the International Space Station. To meet the growing need for radioprophylactics, we
seek to determine the radioprotective efficacy of dietary administration of highly radiation-resistant non-
pathogenic fungi. Drosophila are natural fungivores. In addition, Drosophila are an excellent model system in
which to study the damaging effect of radiation exposure on various organ systems since they share many
similarities with vertebrates yet are easily manipulated with sophisticated genetics and cell biology. We
hypothesize that consumption of these fungal strains will increase resistance to acute radiation damage
through known and unidentified factors. To do this, we will feed three Drosophila genotypes a panel of highly
radioresistant fungi. In addition to wild type flies, we will also test whether radioresistant fungi confer
radiation resistance to two mutant Drosophila strains that accumulate oxidative damage. To test our
hypothesis, we propose a single Aim. We will exposure the flies to gamma irradiation and test if the selected
dietary fungi confer radioprotection to lifespan, the gastrointestinal tract, the ovary, and various biomolecules.
We expect to find a radioprotective effect of dietary radioresistant fungi at one or several levels of our studies
from organismal to molecular. Knowledge gained from this research will open the opportunity to screen
hundreds of fungi using a relatively simple method. Once protective fungal strains are identified, future studies
can test their effectiveness in vertebrates, as well as identify the molecules responsible.
Public Health Relevance Statement
PROJECT NARRATIVE:
Our risk of radiation exposure, whether terrestrial or during space flight, continues to increase creating an
urgent need to identify radioprophylactics to combat irradiation injury. Remarkably radioresistant naturally
occurring fungi offer a unique and powerful system to identify irradiation countermeasures. Our proposal will
test dietary supplementation with radioresistant fungi using Drosophila to identify radioprophylactics.
No Sub Projects information available for 1R21OD034471-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21OD034471-01A1
Patents
No Patents information available for 1R21OD034471-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21OD034471-01A1
Clinical Studies
No Clinical Studies information available for 1R21OD034471-01A1
News and More
Related News Releases
No news release information available for 1R21OD034471-01A1
History
No Historical information available for 1R21OD034471-01A1
Similar Projects
No Similar Projects information available for 1R21OD034471-01A1